NIKKEI 225
27,950.25+402.25(+1.46%)HANG SENG
26,835.27-486.71(-1.78%)CRUDE OIL
71.92-0.15(-0.21%)GOLD FUTURES
1,807.20+5.40(+0.30%)DOW
35,061.55+238.15(+0.68%)BTC-GBP
27,690.88+2,859.53(+11.52%)
DBV Technologies S.A. (DBVT)
| Previous close | 5.03 |
| Open | 5.41 |
| Bid | 5.00 x 1300 |
| Ask | 6.80 x 900 |
| Day's range | 5.31 - 5.47 |
| 52-week range | 1.35 - 7.38 |
| Volume | 51,942 |
| Avg. volume | 91,692 |
| Market cap | 605.573M |
| Beta (5Y monthly) | 2.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.35 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.26 |
- Globe Newswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2021
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights06/30/202155,011,687 Total gross of voting rights: 55,011,687 Total net* of voting rights: 54,933,812 * Total net = total number of voting rights attached to shares – shares withou
- Globe Newswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2021
Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights05/31/202155,011,687 Total gross of voting rights: 55,011,687 Total net* of voting rights: 54,943,413 * Total net = total number of voting rights attached to shares – shares without
- Globe Newswire
DBV Technologies to Present at Upcoming Investor Conferences
Montrouge, France, June 2, 2021 DBV Technologies to Present at Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will participate in upcoming virtual investor conferences in June. Goldman Sachs Global Healthcare Conference The fireside chat will take place on June 8, 2021 at 8:50am ET. JMP Life Sciences Conference The fireside chat
